Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Netarsudil (Rhopressa) Real-world Study in Glaucoma and Ocular Hypertension
NCT03808688Phase 4Completed
- Sponsor
- Aerie Pharmaceuticals
- Start
- Dec 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of netarsudil in open-angle glaucoma (OAG), ocular hypertension, sponsored by Aerie Pharmaceuticals. Started Dec 2018; status: completed.
02
Drugs
netarsudil
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT03808688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03808688.